Mersana Therapeutics Inc (MRSN)
2.33
-0.07
(-2.92%)
USD |
NASDAQ |
May 31, 16:00
2.335
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Revenue (Annual): 36.86M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 36.86M |
| December 31, 2022 | 26.58M |
| December 31, 2021 | 0.043M |
| December 31, 2020 | 0.828M |
| December 31, 2019 | 42.12M |
| Date | Value |
|---|---|
| December 31, 2018 | 10.59M |
| December 31, 2017 | 17.54M |
| December 31, 2016 | 25.17M |
| December 31, 2015 | 10.36M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.043M
Minimum
2021
42.12M
Maximum
2019
21.29M
Average
26.58M
Median
2022
Revenue (Annual) Benchmarks
| Amicus Therapeutics Inc | 399.36M |
| Insmed Inc | 305.21M |
| Altimmune Inc | 0.426M |
| InfuSystems Holdings Inc | 125.78M |
| Anavex Life Sciences Corp | -- |